This document provides an overview of essential information necessary for understanding mental health and substance use disorder parity and how to implement and comply with federal parity laws. This guide applies to parity laws in employer-sponsored health plans and group and individual insurance.

This brochure informs patients about buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts. It reviews effective medications, including methadone, buprenorphine, and naltrexone. The guide also provides strategies to increase the use of MAT in drug court programs.

This resource guide equips mayors and other local public health officials with strategies and resources to shape community responses that promote mental health and substance use disorder recovery, and ensure that needed treatments and services are available.

This fact sheet answers common questions for behavioral health treatment and service providers about the International Classification of Diseases, 10th Edition (ICD-10) code sets.

This report presents findings on compliance with the Synar Amendment aimed at decreasing youth access to tobacco. It reviews progress in enforcing state youth tobacco access laws and reducing the percentage of retailers selling tobacco products to minors.